Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Good Morning! Latin America.
June 2025
| Mo | Tu | We | Th | Fr | Sa | Su |
|---|---|---|---|---|---|---|
| 1 | ||||||
| 2 | 3 | 4 | 5 | 6 | 7 | 8 |
| 9 | 10 | 11 | 12 | 13 | 14 | 15 |
| 16 | 17 | 18 | 19 | 20 | 21 | 22 |
| 23 | 24 | 25 | 26 | 27 | 28 | 29 |
| 30 |
July 2025
| Mo | Tu | We | Th | Fr | Sa | Su |
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | 6 | |
| 7 | 8 | 9 | 10 | 11 | 12 | 13 |
| 14 | 15 | 16 | 17 | 18 | 19 | 20 |
| 21 | 22 | 23 | 24 | 25 | 26 | 27 |
| 28 | 29 | 30 | 31 |
August 2025
| Mo | Tu | We | Th | Fr | Sa | Su |
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | ||||
| 4 | 5 | 6 | 7 | 8 | 9 | 10 |
| 11 | 12 | 13 | 14 | 15 | 16 | 17 |
| 18 | 19 | 20 | 21 | 22 | 23 | 24 |
| 25 | 26 | 27 | 28 | 29 | 30 | 31 |
Press releases published on July 29, 2025
Telix H1 2025 Results: Investor Webcast Notification
GlobeNewswire
·
July 29, 2025
MELBOURNE, Australia and INDIANAPOLIS, July 30, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today advises that it will release its financial results for the half-year ended 30 June 2025 on Thursday 21 August 2025 …
SCCG Management Partners with Crowe Uruguay to Deliver Live Casino Audit & Compliance Training Program
EIN Presswire
·
July 29, 2025
This initiative is designed to strengthen the operational oversight and audit readiness of government regulators responsible for gaming activity in Uruguay. LAS VEGAS, NV, UNITED STATES, July 29, 2025 /EINPresswire.com/ -- SCCG Management, a global …
Maxus Mining Announces Closing of Private Placement for Gross Proceeds of CDN $3,605,770
GlobeNewswire
·
July 29, 2025
VANCOUVER, British Columbia, July 29, 2025 (GLOBE NEWSWIRE) -- Maxus Mining Inc. (“Maxus” or the “Company”) (CSE: MAXM | FRA: R7V), is pleased to announce that is has closed its non-brokered private placement (the “Offering”) previously announced on June …
Rakovina Therapeutics Announces Stock Option Grants
GlobeNewswire
·
July 29, 2025
VANCOUVER, British Columbia, July 29, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSXV: RKV) (FSE: 7JO0) (the “Company” or “Rakovina”), a biopharmaceutical company advancing cancer therapies through artificial intelligence (AI)-powered drug …
Greenlight Capital Re, Ltd. Schedules Second Quarter 2025 Financial Results and Conference Call
GlobeNewswire
·
July 29, 2025
GRAND CAYMAN, Cayman Islands, July 29, 2025 (GLOBE NEWSWIRE) -- Greenlight Capital Re, Ltd. (NASDAQ: GLRE) (the "Company" or "Greenlight Re"), a multiline property and casualty insurer and reinsurer, today announced that it expects to release financial …
Vitrectomy Devices Market: Key Players, Industry Analysis, Potential Growth, Forecast to Reach $1.7 Billion by 2032
EIN Presswire
·
July 29, 2025
Vitrectomy Devices Market is estimated to reach $1.7 billion by 2032. The study integrated high-quality data, professional opinions and analysis. WILMINGTON, DE, UNITED STATES, July 29, 2025 /EINPresswire.com/ -- Allied Market Research published a …
Perla Global Capital Advisors Obtains Default Judgment Against Empresas Ares SRL - Jose Alberto Gerardo Ares Guzman CEO
EIN Presswire
·
July 29, 2025
Perla Global Capital Advisors Obtains Default Judgment Against Empresas Ares SRL and Jose Alberto Gerardo Ares Guzman, Chief Executive Officer and Shareholder LOS ANGELES, CA, UNITED STATES, July 28, 2025 /EINPresswire.com/ -- Perla Global Capital …
New Mexico Manufacturers Meet with Vasquez, Speak Out Against Tariffs’ Harm on Local Businesses
EIN Presswire
·
July 29, 2025
SUNLAND PARK, NM, UNITED STATES, July 29, 2025 /EINPresswire.com/ -- On July 28, 2025, U.S. Representative Gabe Vasquez (NM-02) met with local leaders from Santa Teresa’s manufacturing sector who voiced intense concerns about how the administration’s …
LYNO Launches Presale for AI-Powered Cross-Chain Arbitrage Protocol
GlobeNewswire
·
July 29, 2025
ROAD TOWN, British Virgin Islands, July 29, 2025 (GLOBE NEWSWIRE) -- LYNO, a decentralized cross-chain arbitrage protocol powered by artificial intelligence, has officially launched the first round of its presale, offering early supporters the opportunity …
RECORDATI: STRONG MOMENTUM OF THE GROUP CONTINUES IN THE FIRST HALF OF 2025 REVENUE +11.7%, EBITDA(1) +9.6%, ADJUSTED NET INCOME(2) +8.9%
GlobeNewswire
·
July 29, 2025
Consolidated net revenue of € 1,323.8 million in the first half of 2025, +11.7% or +7.8% on a like-for-like basis(3) and at constant exchange rates (CER) EBITDA(1) of € 496.3 million, +9.6%, margin on revenue of 37.5% Adjusted net income(2) of € …
Apex Digital 3.0 Launch: Bridging Traditional and On-Blockchain Finance Globally
EIN Presswire
·
July 29, 2025
HAMILTON, BERMUDA, July 29, 2025 /EINPresswire.com/ -- • The launch of Apex Digital 3.0 delivers a digitally enabled single source solution across the whole value chain from asset and fund creation to distribution. • With the use of its existing …
Kommunitas Migrates to BNB Chain, Ushering in a New Era of Scalability and Efficiency
GlobeNewswire
·
July 29, 2025
Strategic migration marks a major milestone in Kommunitas’ growth as it pivots to scalable infrastructure and shifts tokenomics to reward long-term holders JAKARTA, Indonesia, July 29, 2025 (GLOBE NEWSWIRE) -- Kommunitas, the pioneering tier-less …
Surge Copper Announces Closing of $5.9 Million Private Placement and Provides Update on Concurrent Strategic Investment
GlobeNewswire
·
July 29, 2025
Vancouver, British Columbia, July 29, 2025 (GLOBE NEWSWIRE) -- Not for distribution to U.S. newswire services or dissemination in the United States Surge Copper Corp. (TSXV: SURG) (OTCQB: SRGXF) (Frankfurt: G6D2) (“Surge” or the “Company”) is pleased to …
eToro Continues Journey Towards a Tokenized Future With Launch of 24/5 Trading, Futures and Tokenized Stocks
GlobeNewswire
·
July 29, 2025
NEW YORK, July 29, 2025 (GLOBE NEWSWIRE) -- eToro Group Ltd. (“eToro”, or the “Company”) (NASDAQ: ETOR), the trading and investing platform, revealed today in a global webinar ‘eToro Unlocked: Trade Without Boundaries’ how the company is evolving its …
Altanine Names Charles J. Andres, Ph.D., J.D., as CEO to Lead Clinical and Strategic Expansion
GlobeNewswire
·
July 29, 2025
LOS ANGELES, July 29, 2025 (GLOBE NEWSWIRE) -- Altanine, Inc., a pharmaceutical company advancing proprietary drug delivery technologies across high-growth therapeutic areas, today announced the appointment of Charles J. Andres, Ph.D., J.D., as its new …
AIM ImmunoTech Announces Pricing of $8.0 Million Public Offering
GlobeNewswire
·
July 29, 2025
OCALA, Fla., July 29, 2025 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (the “Company”), today announced the pricing of a public offering of an aggregate of 2,000,000 shares of its common stock (or pre-funded warrants in lieu thereof), …
Achieve Life Sciences to Participate in the BTIG Virtual Biotechnology Conference
GlobeNewswire
·
July 29, 2025
SEATTLE and VANCOUVER, British Columbia, July 29, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treatment of …
Quoin Pharmaceuticals Provides Product Portfolio Update
GlobeNewswire
·
July 29, 2025
Lead Product, QRX003, Being Tested in Two Active Registrational Clinical Studies for Netherton Syndrome Across the U.S., Europe, and the Middle East. QRX003 Peeling Skin Syndrome Clinical Program Continues Following Positive Initial Data Topical Rapamycin …
UroGen Pharma to Report Second Quarter 2025 Financial Results on Thursday, August 7th, 2025
GlobeNewswire
·
July 29, 2025
Conference Call and Webcast Scheduled for Thursday, August 7th, 2025, at 10:00 AM ET PRINCETON, N.J., July 29, 2025 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions …
Praxis Precision Medicines to Host Conference Call to Announce Topline Results from the RADIANT Trial and Provide Second Quarter 2025 Financial Results
GlobeNewswire
·
July 29, 2025
BOSTON, July 29, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by …